STAT October 2, 2023
Just two years after the World Health Organization’s historic recommendation of the first malaria vaccine, the global health agency on Monday recommended a second, seeking to broaden access to a tool it hopes can save lives.
The vaccine, called R21/Matrix-M, was developed by the University of Oxford and will be produced by the Serum Institute of India, the world’s largest vaccine manufacturer.
The WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Group (MPAG) found no significant difference between the efficacy of the two vaccines. When delivered in a similar way — and administered at first right before the high-transmission period of the disease — both multi-dose vaccines were found to have an efficacy of...
Today's Sponsors
Today's Sponsor